MoonLake Immunotherapeutics: Form SCHEDULE 13D/A, filed Jun 29, 2026
Filed with the SEC on Jun 29, 2026 and accepted by EDGAR at Jun 29, 2026, 17:20 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000921895-26-001697. Last ingested by Listed: Nov 4, 2026, 07:34 ET. Listed shows no prices and gives no investment advice.